India, March 26 -- image credit- freepik

As India's healthcare landscape evolves with cutting-edge diagnostic solutions, Chennai is set to witness a transformative development in Alzheimer's screening. The Mispa i60, introduced at Neuberg Diagnostics, Chennai, offers a simple blood test to detect early signs of Alzheimer's disease using only a blood sample, making it a non-invasive and cost-effective screening option. This test serves as an adjunct to clinical evaluation and does not replace neuroimaging or cerebrospinal fluid (CSF) testing.

This technology leverages p-tau and amyloid proteins, which are strongly associated with Alzheimer's disease, enabling the detection of early pathological changes well before noticeable cognitive de...